web analytics
25 C
Munich
Thursday, August 11, 2022

Emergent Health (OTCMKTS: EMGE) Big Week as RM Runner Closes on Acquisitions and Looks to Go Fully Reporting

Emergent Health (OTCMKTS: EMGE) continues to make steady gains up the charts in recent trading running all of last week and closing the week off strong up 25% on Friday on $1 million in dollar volume. The stock is under heavy accumulation and is quickly turning into one of the top most searched for stocks on the OTC. Blessed with a tight share structure EMGE is one reverse merger that has not disappointed so far and has a lot of room to grow. EMGE is now closing on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields and bringing on executive Jim Morrison, the former president of L’Oréal as the new CEO of Emergent upon the acquisition of Evolutionary Biologics, expected to close within the next three weeks. Emergent plans to create a complete human and pet portfolio and become a major participant in the field of OTC human and pet products. Fusion Specialty Pharmacy is a nationally accredited compounding pharmacy licensed in 27 states and located in St. George, Utah dedicated to formulating creative, individualized, and compounded medications. Fusion generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. New CEO Jim Morrison has big plans for Emergent including continued growth through acquisition, becoming fully reporting and uplisting to the big boards. 

EMGE is making some big moves reporting last week its pending Acquisition Evolutionary Biologics, Inc., engages By Design Medical, a DBA of Aesthetics By Design to market, sell and distribute Regenerative Medicine Products produced by Evolutionary Biologics. The initial focus shall be Exo Elixir TM, a sub-dermal regenerative serum derived from dermal fibroblast stem cells with a proprietary mixture of growth factors, cytokines, collagen, and soluble matrix proteins ideal for skin cells to regenerate themselves to the Aesthetic Trade. The global biologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030. The Company also retained Imagemme, a leading award-winning creative branding and packaging studio to create “The Wholistic Company”, a consolidation of its current and future health, wellness and regenerative products. The intent is to have uniform branding and develop marketing and distribution strategies for multi-channel sales approaches. This new brand will be marketed via on-line direct to consumer sales, traditional retail sales and other forms of sales channels, including TV Shopping and “Contact Purchasing.” 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Emergent Health (OTCMKTS: EMGE) Curates Companies and Products, Develops and Sells in the Regenerative Health Space … Its products comprise ingestibles as well as topicals for the whole family. The company distributes its products online and through Content Based Shopping using Influencers to position products in their produced content throughout the United States and Internationally. PharmaZu Corp., its newly acquired subsidiary, is a pure play, e-commerce products and service provider focused on The Pet Community, Pet Pharmacy and Wellness using Influencers and their content, including the pet pharmacy, vet telehealth and pet wellness businesses. Emergent does not claim any of its products are approved by the FDA to diagnose, treat, cure or prevent any disease. 

Jim Morrison, President and CEO of Regen has agreed to join Emergents Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Emergent recently executed a letter of intent to acquire Evolutionary Biologics. The acquisition is expected to close within the next three weeks.  Mr. Morrison is a legend in the personal care industry, most notably as President of L’Oréal. While at L’Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. He is considered one of the top brand strategists in the personal care space. Morrison has had a long history of working with celebrities in the beauty space. Business Week Magazine previously wrote, “Over the last two decades, Mr. Morrison has had a profound impact on the American Beauty Industry. In the industry’s history no other executive has had the level of financial responsibility or breadth of organizational experience as Jim. His devotion to, and success within the American Beauty Industry is unmatched.” 

Regen Biowellness products include:

Product with Issued Patents

Immuniain TM (Immune Booster) – Irreversibly-inactivated pepsinogen fragments for modulating immune function (Immune Booster- FDA Cleared) ImmunaZin contains an FDA approved New Dietary Ingredient (NDI), and the NDI # is 1140 Patent No. US 8,309,072; Patent Issued: November 13, 2012

Pending Patent Applications

Veterinary Cannabinoid and Menthol Compositions and Methods
Application No. 16/419,392; International Application PCT/US2019/048695

Cannabinoid and Menthol Compositions and Methods
US Application No. 16/419,336; International Application PCT/US2019/048691

Thin Film Toothpaste Strip, European Application
Product Name: KidzStrips ®

Thin Film Toothpaste Strip, Eurasian Application
Product Name: KidzStrips ®

Fertilizer
Product Name: HydroSoil ®, Water retaining Hemp enhanced fertilizer, water plant once every two weeks

Other Products

IcyEase
Adhesive Ice Pack for muscle/joint pain to cool surface and address pain.

Patent-pending, FDA pain claim in progress. IcyEase contains menthol, menthol is an approved pain relief ingredient in the FDA’s monograph for topical pain relief

Micro Voltage Trans Derm C
Patent application in progress for pain with unique and superior absorbing features due to wearer’s movement generated Micro Voltage

Silverpro – our only FDA approved medical device for the treatment of pain. Revolutionary technology combining genuine silver yarn with low-static carbon fibers, to create the world’s most advanced-compression pain relief fabric

https://twitter.com/SalHaro1/status/1553122140781613056

To Find out the inside Scoop on EMGE Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

EMGE

EMGE reported last week its pending Acquisition Evolutionary Biologics, Inc., (Evolutionary Biologics), a market leading innovator of regenerative biological products using science and technology to build products creating external beauty engages By Design Medical, a DBA of Aesthetics By Design to market, sell and distribute Regenerative Medicine Products produced by Evolutionary Biologics. The initial focus shall be Exo Elixir TM, a sub-dermal regenerative serum derived from dermal fibroblast stem cells (does not contain any live cells) with a proprietary mixture of growth factors, cytokines, collagen, and soluble matrix proteins ideal for skin cells to regenerate themselves to the Aesthetic Trade. The global biologics market size was valued at US $366.43 billion in 2021 and it is expected to hit over US$ 719.84 billion by 2030 with a noteworthy CAGR of 7.8% from 2022 to 2030Tamara Paul, CEO of By Design Medical, a DBA of Aesthetics By Design stated “Aesthetics By Design is pleased to begin the collaboration with Evolutionary Biologics. Together our companies will change the landscape of regenerative medicine and launch revolutionary innovated products into the aesthetics market. The acquisition of Evolutionary Biologics by Emergent Health is expected to close within the next two weeks. 

On July 28 EMGE announced it has retained Imagemme, a leading award-winning creative branding and packaging studio to create “The Wholistic Company”, a consolidation of its current and future health, wellness and regenerative products. The intent is to have uniform branding and develop marketing and distribution strategies for multi-channel sales approaches. This new brand will be marketed via on-line direct to consumer sales, traditional retail sales and other forms of sales channels, including TV Shopping and “Contact Purchasing.” 

James W. Zimbler, CEO of Emergent stated, “I couldn’t be happier about the anticipated opportunity to combine and brand our current line of quality products with Regen Biowellness and Evolutionary Biologics fantastic respective product lines into one consistent brand. With the addition and expected addition to our management team of Marvin Segel, son of QVC Founder Joseph Segel with over 20 years of direct-to-consumer TV and marketing success and Jim Morrison, a legend in the personal care industry, most notably as President of L’Oréal, we believe Emergent’s newly formed brand “The Wholistic Company”, will become a recognizable household name to consumers.” 

Jim Morrison, President/CEO of Evolutionary Biologics, stated, “Imagemme is a cutting-edge branding agency. They have the ability to create a memorable brand for “The Wholistic Company” based upon the extensive portfolio of products that our combined companies will own and develop.” 

https://twitter.com/MattRiv2/status/1553143047076003840

For More on EMGE Subscribe Right Now!

Currently trading at a $5.7 million market valuation EMGE has 161,351,111 shares outstanding out of 200 million authorized, 50,327,516 of which are restricted leaving just 25,523,595 free trading shares and float of 4,083,089 shares. EMGE is an exciting story developing in small caps; while the Company has little assets, they do have some revenues and are virtually debt free. In recent months the Company is in the process of completing 3 major acquisitions including Fusion Specialty Pharmacy which generated $3,801,497 in 2021 Revenues, an approximate 100% increase from 2020 Revenues of $1,971,599. They are also acquiring Revolutionary Biologistics and just announced it is closing in on the acquisition of Regen Biowellness, Inc. a distributor of various products in the plant-based and regenerative medical fields. The Acquisition is expected to close on or about August 1st, 2022. Jim Morrison, President and CEO of Regen has agreed to join Emergent’s Board of Directors upon the acquisition of Regen and additionally become the full-time CEO of Emergent upon the acquisition of Evolutionary Biologics. Mr. Morrison is a legend in the personal care industry, most notably as President of L’Oréal. While at L’Oréal, Morrison oversaw growth that averaged more than 20% year-over-year. He engineered the acquisitions of Redken and Matrix and led the company during a period of unprecedented growth during his tenure. New CEO Jim Morrison has big plans for Emergent including continued growth through acquisition, becoming fully reporting and uplisting to the big boards. Microcapdaily will be covering EMGE so make sure you subscribe to Microcapdaily right now so you don’t miss it. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in EMGE either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.